Jan Van Droogenbroeck
Jan Van Droogenbroeck publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #3,968,292 of 7,710,434 ranked researchers
- Rank in Belgium
- #35,674 of 67,186
- Works
- 69
- Citations
- 1.6k
- Citations per work
- 23.2
What does Jan Van Droogenbroeck research?
Jan Van Droogenbroeck's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3449.1%
- Medicine3449.1%
- Everything else2536.1%
- Life Sciences1014.8%
- 1Hematology25% of their works
- 2Genetics10% of their works
- 3Molecular Biology10% of their works
- 4Oncology10% of their works
- 5Immunology4% of their works
- 6Physiology4% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Acute Myeloid Leukemia Research
- Protein Degradation and Inhibitors
- Hematopoietic Stem Cell Transplantation
Which keywords describe Jan Van Droogenbroeck's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Prognostic Factors, Hematopoietic Stem Cells, Chronic Lymphocytic Leukemia, Genomic Aberrations, BCR-ABL and Imatinib.
- PROTACs
- Bone Marrow Niche
- Acute Myeloid Leukemia
- Transthyretin
- Myelofibrosis
- Imatinib
- Genomic Aberrations
- Hematopoietic Stem Cells
- International Myeloma Working Group
- Diagnosis Criteria
- Prognostic Factors
- Chronic Lymphocytic Leukemia
- BCR-ABL
- JAK2 Mutation
- Cardiac Amyloidosis
- AML
- BET Bromodomains
- Graft-versus-Host Disease
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Diagnosis Criteria211 topic
- International Myeloma Working Group211 topic
- Prognostic Factors152 topics
- Hematopoietic Stem Cells102 topics
- Chronic Lymphocytic Leukemia91 topic
- Genomic Aberrations91 topic
- BCR-ABL81 topic
- Imatinib81 topic
- JAK2 Mutation81 topic
- Myelofibrosis81 topic
- Cardiac Amyloidosis71 topic
- Transthyretin71 topic
- AML61 topic
- Acute Myeloid Leukemia61 topic
- BET Bromodomains41 topic
- Bone Marrow Niche41 topic
- Graft-versus-Host Disease41 topic
- PROTACs41 topic
Where does Jan Van Droogenbroeck work?
Jan Van Droogenbroeck's main affiliation in the publication record is AZ Sint-Jan, Belgium.
How many publications and citations does Jan Van Droogenbroeck have?
OpenAlex counts 69 works and 1,603 citations for Jan Van Droogenbroeck, an h-index of 15, ranking #3,968,292 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jan Van Droogenbroeck. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.